Live from the NIH registry
Studies recruiting near Boston right now
Top 25 of 2,960 recruiting studies, sorted by proximity — each links to its official registry page
RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer
Endometrial Cancer
Phase 2
Interventional 110 participants sought
Massachusetts General Hospital Cancer Center — Boston, Massachusetts (3.0 mi)
· Sponsor: Dana-Farber Cancer Institute
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Phase 2
Interventional 120 participants sought
Dana-Farber Cancer Institute — Boston, Massachusetts (3.0 mi)
· Sponsor: Nationwide Children's Hospital
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Dana-Farber Cancer Institute — Boston, Massachusetts (3.0 mi)
· Sponsor: National Cancer Institute (NCI)
Extracellular Vesicle Micro RNA Profiling in Congenital Heart Disease: Fetal-Maternal Regulation in Neonatal Thrombosis
Congenital Heart Disease, Single-ventricle
N/A
Observational 10 participants sought
Boston Children's Hospital — Boston, Massachusetts (3.0 mi)
· Sponsor: Boston Children's Hospital
Effects of IL-1 Beta Inhibition on Vascular Inflammation in TET2 Clonal Hematopoiesis
Vascular Inflammation, ASCVD
Phase 2
Interventional 120 participants sought
Massachusetts General Hospital — Boston, Massachusetts (3.0 mi)
· Sponsor: Massachusetts General Hospital
HLA Demographics Study in Adults With Type 1 Diabetes
Diabetes Mellitus, Type I
N/A
Observational 200 participants sought
Joslin Diabetes Center — Boston, Massachusetts (3.0 mi)
· Sponsor: GentiBio, Inc
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Beth Israel Deaconess Medical Center ( Site 0161) — Boston, Massachusetts (3.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
BE WELL With Migraine: Brain Education and WELLness With Migraine
Migraine
N/A
Interventional 286 participants sought
Cambridge Health Alliance - Center for Mindfulness and Compassion — Cambridge, Massachusetts (4.0 mi)
· Sponsor: Wake Forest University Health Sciences
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
Alcohol Use Disorder, Cannabis Use Disorder
N/A
Interventional 294 participants sought
MGH Department of Psychiatry — Boston, Massachusetts (3.0 mi)
· Sponsor: Massachusetts General Hospital
Improving Clinical Efficiency by Reducing Scheduled Follow-ups Using Cochlear America's Population Mean Mapping Strategy
Deafness, Cochlear Hearing Loss
N/A
Interventional 48 participants sought
Mass Eye and Ear — Boston, Massachusetts (3.0 mi)
· Sponsor: Massachusetts Eye and Ear Infirmary
Music Use in Parturients Admitted to Labor & Delivery
Anxiety, Pain
N/A
Interventional 106 participants sought
Tufts Medical Center — Boston, Massachusetts (3.0 mi)
· Sponsor: Tufts Medical Center
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Tufts Medical Center — Boston, Massachusetts (3.0 mi)
· Sponsor: Relay Therapeutics, Inc.
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Metastatic Solid Tumors
Phase 1
Interventional 600 participants sought
Massachusetts General Hospital (MG) — Boston, Massachusetts (3.0 mi)
· Sponsor: Erasca, Inc.
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — Boston, Massachusetts (3.0 mi)
· Sponsor: Axsome Therapeutics, Inc.
International Weight Control Registry
Weight Loss, Overweight
N/A
Observational 100,000 participants sought
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University — Boston, Massachusetts (3.0 mi)
· Sponsor: Tufts University
Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial
Graft Vs Host Disease, Acute-graft-versus-host Disease
N/A
Interventional 36 participants sought
Brigham and Women's Hospital — Boston, Massachusetts (3.0 mi)
· Sponsor: Dana-Farber Cancer Institute
APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
Overactive Bladder (OAB), Urinary Urgency
N/A
Interventional 596 participants sought
Curavit — Boston, Massachusetts (3.0 mi)
· Sponsor: Medstar Health Research Institute
Waveform Capnography Compared to Colorimetric Carbon Dioxide Detection During Tracheal Intubation of Critically Ill Adults
Acute Respiratory Failure
N/A
Observational 2,092 participants sought
Lahey Hospital & Medical Center — Burlington, Massachusetts (14.0 mi)
· Sponsor: Brian Driver
Direct to Patient Minimal Risk Biospecimen and Data Collection Research
Healthy, Lupus
N/A
Observational 100,000 participants sought
Joined Bio — Lexington, Massachusetts (11.4 mi)
· Sponsor: Joined Bio
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Solid Tumors
Phase 2
Interventional 170 participants sought
Local Institution - 0092 — Boston, Massachusetts (3.0 mi)
· Sponsor: Mirati Therapeutics Inc.
Randomized Single Center Study to Evaluate Tolerability, Symptoms, and Visual Functional Outcomes With the Use of OTC Lubricating Eye Drops in Subjects With Dry Eye Disease
Dry Eye Disease (DED)
Phase 4
Interventional 60 participants sought
Andover Eye Associates — Andover, Massachusetts (23.6 mi)
· Sponsor: Andover Research Eye Institute
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Boston Veteran's Affairs Medical Center — Jamaica Plain, Massachusetts (1.9 mi)
· Sponsor: SWOG Cancer Research Network
Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)
Diabetes Mellitus, Type 2
N/A
Interventional 119,680 participants sought
President and Fellows of Harvard College, T.H. Chan School — Boston, Massachusetts (3.0 mi)
· Sponsor: Stanford University
Treatment of UC With Novel Therapeutics
Ulcerative Colitis Mild, Ulcerative Colitis
Phase 2
Interventional 20 participants sought
Brigham and Women's Hospital — Chestnut Hill, Massachusetts (4.2 mi)
· Sponsor: Brigham and Women's Hospital
Radiation Free Study
Aortic Aneurysm
N/A
Interventional 182 participants sought
Beth Israel Deaconess Medical Center — Boston, Massachusetts (3.0 mi)
· Sponsor: Philips Clinical & Medical Affairs Global